- ABOUT ME
- AREAS OF FOCUS
- EDUCATION & LEADERSHIP
- LOCATIONS & HOSPITALS
- NEWS & PUBLICATIONS
Dr. Shaw received her bachelor’s degree in biochemistry from Oakland University in Rochester, MI and attended medical school at Oregon Health & Science University, where she completed her dermatology internship and residency and was also Chief Resident her senior year. She is board certified in dermatology. Dr. Shaw spent four years as an Assistant Professor of Dermatology at Oregon Health & Science University and was most recently practicing Dermatology at Providence Medical Group in Portland before joining The Oregon Clinic Portland Dermatology.
Dermatology appealed to Dr. Shaw because it is a very visual field, and that she can look at someone’s skin and know how to help them. She enjoy meeting people, hearing their life stories, and being trusted with their skin concerns. She feels that no concern is too small and helping patients resolve their issues is a great reward.
Dr. Shaw is trained to check skin for possible skin cancer, as well as remove skin cancer with minor procedures, diagnose and treat inflammatory skin disease in adults and children, perform skin biopsies, excisions, removal of benign growths, patch testing, Botox injections for axillary hyperhidrosis and cosmetic Botox.
Dr. Shaw has lived in the Portland area for almost 20 years and loves the mix of small and big city feel, great food, and proximity to a variety of outdoors activities. Outside of work, she enjoys spending time with her husband and two children, skiing, hiking, and traveling.
Member, American Medical Association
Member, Oregon Dermatology Society
Member, American Academy of Dermatology
Member, Alpha Omega Alpha Medical Honor Society
EDUCATION & TRAINING
Chief Resident, Dermatology, Oregon Health & Science University, Portland, OR, 2009
Residency, Dermatology, Oregon Health & Science University, Portland, OR, 2009
Internship, Internal Medicine, Oregon Health & Science University, Portland, OR, 2006
MD, Oregon Health & Science University, Portland, OR, 2005
BS, Oakland University, Rochester, MI, 1998
AAS, St. Clair Community College, Port Huron, MI, 1996
Shaw, T., Simpson, B., Wilson, B., Oostman, H., Rainey, D, Storrs, F. True photoallergy to sunscreens is rare despite popular belief. Dermatitis, 2010 (in print).
Shaw, T., Currie, G., Simpson, E. Eczema prevalence in the United States: Data from the 2003 National Survey of Children’s Health. JID 2010 (pending)
Shaw, T., Oostman, H., Rainey, D., Storrs, F. A rare eyelid dermatitis allergen: shellac in popular mascara. Dermatitis 2010 (in print)
Stevens, S., Shaw, T., Dykhuizen, E., Lessov, N., Hill, J., Wurst, W., Stenzel-Poore, M. (2003) Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and astrocytes that express CRH-R1. J Cereb Blood Flow Metab 2003 (10): 1151-9.
Stenzel-Poore, M., Stevens, S., Xiong, Z., Lessov, N., Harrington, C., Mori, M., Meller, R., Rosenzweig, H., Tobar, E., Shaw, T., Chu, X., Simon, R. Effect of ischemic preconditioning on genomic response to cerebral ischemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003, 362 (9389): 1028-37.
Maiese, K., Vincent, A., Lin S., Shaw, T. Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection. J Neurosci Res 2000 62 (2): 257-72.
Lin, S., Vincent, A., Shaw, T., Maynard, K., Maiese, K. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J Cereb Blood Flow Metab 2000 20(9): 1380-91.